A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT00634270 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Alabama at Birmingham

Collaborators